Recent Finacing
Recent Raise
Chiasma is a biopharmaceutical company developing oral peptide therapeutics using proprietary Transient Permeability Enhancer (TPE) technology, advancing octreotide capsules (Phase 3) for acromegaly and a CKD-related small molecule.
